QMS Medical Allied Services Limited — Q1FY27 earnings call summary

Filed 21 August 2026 · Official transcript

Q1 FY27 consolidated revenue INR56.9 Cr, +22% y-y; EBITDA INR8.3 Cr, +27% y-y; PAT INR4 Cr, +25% y-y
EBITDA margin improved to 14.6% vs 14.1% in Q1 FY26 and 13.3% in Q4 FY26
Saarathi Healthcare 76% owned; full acquisition expected by Q2 FY27
Q Devices revenue INR3 Cr in Q1; targeting 10-15% contribution in FY27 and 20-25% of product revenue in 3 years
FY27 service revenue guidance INR90-100 Cr; total revenue guidance ~INR220 Cr maintained
Employee expenses increased due to PSP hiring; expected stable run rate with possible increases on new contracts
Q1 revenue up 28% q-q; EBITDA +41% q-q; PAT more than doubled q-q
Gross margin expansion driven by higher services revenue share (40% in Q1 vs 30% last year)